These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 2230411)

  • 21. [Clinical aspects of bone mineral content in osteoporosis].
    Nishizawa Y; Miki T; Nakatsuka K; Hagiwara S; Iba K; Morii H
    Nihon Ronen Igakkai Zasshi; 1992 Apr; 29(4):257-61. PubMed ID: 1614003
    [No Abstract]   [Full Text] [Related]  

  • 22. Assessment of risk factors for low bone mineral density in Brazilian postmenopausal women.
    Nahas EA; Kawakami MS; Nahas-Neto J; Buttros Dde A; Cangussu L; Rodrigues AB
    Climacteric; 2011 Apr; 14(2):220-7. PubMed ID: 20642330
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Postmenopausal osteoporosis and alendronate.
    Pérez-López FR
    Maturitas; 2004 Jul; 48(3):179-92. PubMed ID: 15207883
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Screening for osteoporosis in postmenopausal women: recommendations and rationale.
    Berg AO
    Am J Nurs; 2003 Jan; 103(1):73-80; discussion 81. PubMed ID: 12544063
    [No Abstract]   [Full Text] [Related]  

  • 25. A multicenter cross sectional study on bone mineral density in rheumatoid arthritis. Italian Study Group on Bone Mass in Rheumatoid Arthritis.
    Sinigaglia L; Nervetti A; Mela Q; Bianchi G; Del Puente A; Di Munno O; Frediani B; Cantatore F; Pellerito R; Bartolone S; La Montagna G; Adami S
    J Rheumatol; 2000 Nov; 27(11):2582-9. PubMed ID: 11093437
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Osteoporosis. Clinical features, prevention, and treatment.
    Gambert SR; Schultz BM; Hamdy RC
    Endocrinol Metab Clin North Am; 1995 Jun; 24(2):317-71. PubMed ID: 7656894
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of the relative rates of bone mineral content loss in postmenopause due to both estrogen deficiency and ageing.
    Gnudi S; Mongiorgi R; Figus E; Bertocchi G
    Boll Soc Ital Biol Sper; 1990 Dec; 66(12):1153-9. PubMed ID: 2100526
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Assessment of bone quality. Bone quality and osteoporosis treatment].
    Mashiba T
    Clin Calcium; 2008 Mar; 18(3):300-7. PubMed ID: 18310816
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Prevalence and associated factors of osteoporosis among postmenopausal women in Chuncheon: Hallym Aging Study (HAS)].
    Jang SN; Choi YH; Choi MG; Kang SH; Jeong JY; Choi YJ; Kim DH
    J Prev Med Public Health; 2006 Sep; 39(5):389-96. PubMed ID: 17076179
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mechanisms of bone loss.
    Murray TM
    J Rheumatol Suppl; 1996 Aug; 45():6-10. PubMed ID: 8856644
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of chronic liver disease on bone mineral density and bone metabolism markers in postmenopausal women.
    Uretmen S; Gol M; Cimrin D; Irmak E
    Eur J Obstet Gynecol Reprod Biol; 2005 Nov; 123(1):67-71. PubMed ID: 16051419
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Developing factors of osteoporosis].
    Yamamoto K
    Nihon Seikeigeka Gakkai Zasshi; 1990 Jan; 64(1):122-31. PubMed ID: 2181047
    [No Abstract]   [Full Text] [Related]  

  • 33. Decision rules for selecting women for bone mineral density testing: application in postmenopausal women referred to a bone densitometry unit.
    Martínez-Aguilà D; Gómez-Vaquero C; Rozadilla A; Romera M; Narváez J; Nolla JM
    J Rheumatol; 2007 Jun; 34(6):1307-12. PubMed ID: 17552058
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The osteoporosis profile--one more time].
    Rødbro P
    Ugeskr Laeger; 1995 Apr; 157(16):2330-2. PubMed ID: 7652974
    [No Abstract]   [Full Text] [Related]  

  • 35. Urinary hydroxypyridinium crosslinks of collagen as markers of bone resorption and estrogen efficacy in postmenopausal osteoporosis.
    Seibel MJ; Cosman F; Shen V; Gordon S; Dempster DW; Ratcliffe A; Lindsay R
    J Bone Miner Res; 1993 Jul; 8(7):881-9. PubMed ID: 8352070
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Alendronate also for women without established osteoporosis?].
    Klovning A; Norheim OF
    Tidsskr Nor Laegeforen; 2000 Apr; 120(11):1347-51. PubMed ID: 10868100
    [No Abstract]   [Full Text] [Related]  

  • 37. [Osteoporosis after menopause and oophorectomy].
    Ohta H; Masuda A; Komukai S; Nozawa S
    Nihon Rinsho; 1994 Sep; 52(9):2382-94. PubMed ID: 7967085
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Risk of osteoporosis in postmenopausal women. When is bone density measurement indicated?].
    MMW Fortschr Med; 2004 May; 146(21):63. PubMed ID: 15373093
    [No Abstract]   [Full Text] [Related]  

  • 39. [Physiological and pathological aging in bone--contribution of risk factors to bone loss with aging].
    Nakamura T; Orimo H
    Nihon Ronen Igakkai Zasshi; 1991 May; 28(3):318-24. PubMed ID: 1895524
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Diagnosis and treatment of postmenopausal osteoporosis].
    Mizunuma H
    Nihon Rinsho; 2007 Nov; 65 Suppl 9():490-4. PubMed ID: 18161154
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.